Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linhong Li

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Cytotherapy|October 14, 2020
MAGT1 messenger RNA-corrected autologous T and natural killer cells for potential cell therapy in X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia diseaseJulie Brault, Ronald J Meis, Linhong Li, et al.
Science Translational Medicine|January 13, 2017
CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous diseaseSuk See De Ravin, Linhong Li, Xiaolin Wu, et al.
Cell Reports. Medicine|May 5, 2021
Preclinical evaluation for engraftment of CD34<sup>+</sup> cells gene-edited at the sickle cell disease locus in xenograft mouse and non-human primate modelsNaoya Uchida, Linhong Li, Tina Nassehi, et al.
Nature Biotechnology|March 8, 2016
Targeted gene addition in human CD34(+) hematopoietic cells for correction of X-linked chronic granulomatous diseaseSuk See De Ravin, Andreas Reik, Pei-Qi Liu, et al.
Blood|February 24, 2021
Enhanced homology-directed repair for highly efficient gene editing in hematopoietic stem/progenitor cellsSuk See De Ravin, Julie Brault, Ronald J Meis, et al.
Blood Advances|December 7, 2020
NADPH oxidase correction by mRNA transfection of apheresis granulocytes in chronic granulomatous diseaseSuk See De Ravin, Julie Brault, Ronald J Meis, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Cytotherapy|October 14, 2020
MAGT1 messenger RNA-corrected autologous T and natural killer cells for potential cell therapy in X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia diseaseJulie Brault, Ronald J Meis, Linhong Li, et al.
Science Translational Medicine|January 13, 2017
CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous diseaseSuk See De Ravin, Linhong Li, Xiaolin Wu, et al.
Cell Reports. Medicine|May 5, 2021
Preclinical evaluation for engraftment of CD34<sup>+</sup> cells gene-edited at the sickle cell disease locus in xenograft mouse and non-human primate modelsNaoya Uchida, Linhong Li, Tina Nassehi, et al.
Nature Biotechnology|March 8, 2016
Targeted gene addition in human CD34(+) hematopoietic cells for correction of X-linked chronic granulomatous diseaseSuk See De Ravin, Andreas Reik, Pei-Qi Liu, et al.
Blood|February 24, 2021
Enhanced homology-directed repair for highly efficient gene editing in hematopoietic stem/progenitor cellsSuk See De Ravin, Julie Brault, Ronald J Meis, et al.
Blood Advances|December 7, 2020
NADPH oxidase correction by mRNA transfection of apheresis granulocytes in chronic granulomatous diseaseSuk See De Ravin, Julie Brault, Ronald J Meis, et al.
Pageof 6